Quarterly Result14 Feb 2026, 09:32 pm
Brawn Biotech Reports Q3 and Year-to-Date Unaudited Financial Results for 2025
AI Summary
Brawn Biotech Ltd. has released its unaudited financial results for the quarter and nine months ended 31st December 2025. The board of directors approved the results in a meeting held on 14th February 2026. The company, primarily engaged in the pharmaceuticals business, reported a net profit from ordinary activities after tax for the period.
Key Highlights
- Unaudited financial results for Q3 and year-to-date 2025 approved by the board of directors.
- Results reviewed by the audit committee and prepared in compliance with Indian Accounting Standards.
- No separate reportable segments as per Ind-AS 108 dealing with operating segments.
- Net profit from ordinary activities reported for the period.
- Company engaged primarily in the pharmaceuticals business.
Price Impact
More from BRAWN